Neurocrine Biosciences (Nasdaq: NBIX) has announced positive results from its Phase IV KINECT-PRO study, showing that Ingrezza (valbenazine) provided meaningful and sustained benefits for patients ...

It is important for clinicians to understand the causes and symptoms of tardive dyskinesia to avoid common misdiagnoses and ensure effective management.

It is important for clinicians to understand the causes and symptoms of tardive dyskinesia to avoid common misdiagnoses and ensure effective management.

The Number of Grants for each Cancer Type may include grants not 100% focused on that type of cancer. For example, a grant that focuses 90% on breast cancer and 10% on prostate cancer will be counted ...

A new SkillsFuture Workforce Development Grant, which will provide higher funding support of up to 70 per cent for job-redesign activities. From March 2025, Singaporeans can apply for a training ...

Copyright 2025 The Associated Press. All Rights Reserved. Grant Fisher, of the United States, celebrates after winning the bronze medal in the men’s 5000 meters ...

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Q4 2024 Earnings Call Transcript February 6, 2025 Neurocrine Biosciences, Inc. misses on earnings expectations. Reported EPS is $1 EPS, expectations were ...

Q4 revenue was $627.7 million, slightly below the $629 million estimate. Ingrezza remains the main revenue driver, with a 23% increase in quarterly sales to $615 million. Neurocrine Biosciences ...

The eligible man in question? That’d be Grant Ellis, who competed on Jenn’s season and left during week 6. In case you need a refresher, here’s what we know about Grant from his Bachelorette ...

As with other drugs, Ingrezza (valbenazine) can cause side effects, such as drowsiness and parkinsonism. If you are unable to tolerate Ingrezza’s side effects, talk with your doctor or ...